EU | pharmaphorum

EU

News

Pharma incensed by EU's compulsory licensing proposal

Pharma industry bodies have slammed a proposal by the European Commission to set up a compulsory licensing (CL) framework for medicines in emergency situations, claiming t

News

EU sets up €100m fund to tackle health threats

The EU has set aside a €100 million block of financing for small- and medium-sized enterprises working on projects that could tackle public health threats, including emerg

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AZ's Imfinzi/Imjudo combo backed in EU for liver, lung cance...

AstraZeneca's oncology portfolio continues to deliver, with a recommendation for EU approval of its new Imfinzi/Imjudo immunotherapy combination heading a flurry of regulatory updates.

News

CHMP backs Amicus' therapy for Pompe disease

Amicus Therapeutics could be just weeks away from getting EU approval for its new Pompe disease therapy Pombiliti after getting a positive opinion on the drug from the EMA's human medicines

News

CSL closes on EU approval for haemophilia B gene therapy

CSL's gene therapy for haemophilia B has been recommended for approval by the EMA's human medicine committee, setting up a decision by the European Commission early next year.

Pharma incensed by EU's compulsory licensing proposal

EU sets up €100m fund to tackle health threats

Single market at heart of EU plans for pharma reform

AZ's Imfinzi/Imjudo combo backed in EU for liver, lung cance...

CHMP backs Amicus' therapy for Pompe disease

CSL closes on EU approval for haemophilia B gene therapy

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

EU

Editor's Picks